Related Experiment Video
Updated: Aug 16, 2025
Genome-Wide Analysis of DNA Methylation in Gastrointestinal Cancer
Published on: September 18, 2020
Single-Cell DNA Methylation Analysis in Cancer
Hannah O'Neill1, Heather Lee2,3, Ishaan Gupta4
1Department of Pathology, Dunedin School of Medicine, University of Otago, Dunedin 9016, New Zealand.
Abstract:
Morphological, transcriptomic, and genomic defects are well-explored parameters of cancer biology. In more recent years, the impact of epigenetic influences, such as DNA methylation, is becoming more appreciated. Aberrant DNA methylation has been implicated in many types of cancers, influencing cell type, state, transcriptional regulation, and genomic stability to name a few. Traditionally, large populations of cells from the tissue of interest are coalesced for analysis, producing averaged methylome data. Considering the inherent heterogeneity of cancer, analysing populations of cells as a whole denies the ability to discover novel aberrant methylation patterns, identify subpopulations, and trace cell lineages. Due to recent advancements in technology, it is now possible to obtain methylome data from single cells. This has both research and clinical implications, ranging from the identification of biomarkers to improved diagnostic tools. As with all emerging technologies, distinct experimental, bioinformatic, and practical challenges present themselves. This review begins with exploring the potential impact of single-cell sequencing on understanding cancer biology and how it could eventually benefit a clinical setting. Following this, the techniques and experimental approaches which made this technology possible are explored. Finally, the present challenges currently associated with single-cell DNA methylation sequencing are described.
Insights
Single-cell DNA methylation sequencing offers new insights into cancer biology by revealing cellular heterogeneity. This technology aids in identifying biomarkers and improving diagnostics, despite current challenges.
Area of Science:
- Epigenetics and Cancer Biology
- Genomics and Molecular Biology
Background:
- Cancer research traditionally analyzes bulk tissue, averaging epigenetic data and masking cellular heterogeneity.
- Aberrant DNA methylation is crucial in cancer, affecting cell state, gene regulation, and stability.
- Single-cell analysis overcomes limitations of bulk analysis for cancer research.
Purpose of the Study:
- To explore the impact of single-cell sequencing on understanding cancer biology.
- To discuss the potential clinical benefits of single-cell DNA methylation analysis.
- To review the techniques, applications, and challenges of single-cell DNA methylation sequencing.
Main Methods:
- Review of current literature on single-cell DNA methylation sequencing techniques.
- Exploration of experimental approaches enabling single-cell methylome data acquisition.
- Analysis of bioinformatic and practical challenges in the field.
Main Results:
- Single-cell sequencing allows for the discovery of novel aberrant methylation patterns.
- It enables the identification of cancer subpopulations and cell lineage tracing.
- Advancements provide opportunities for biomarker discovery and improved diagnostics.
Conclusions:
- Single-cell DNA methylation sequencing holds significant promise for advancing cancer research and clinical applications.
- Overcoming technical and bioinformatic challenges is key to realizing its full potential.
- This technology is poised to revolutionize our understanding of cancer heterogeneity.
